Related Experiment Video

Updated: Aug 9, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Modulation of apoptosis signaling for cancer therapy

Simone Fulda1, Klaus-Michael Debatin

  • 1University Children's Hospital, Eythstr. 24, D-89075, Ulm, Germany. simone.fulda@uniklinik-ulm.de

Archivum Immunologiae Et Therapiae Experimentalis
|May 3, 2006
PubMed

Insights

Apoptosis, or programmed cell death, is crucial for tissue balance and cancer treatment. Understanding how cancer cells evade apoptosis offers new therapeutic targets for effective cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Apoptosis, the programmed cell death pathway, is essential for maintaining tissue homeostasis.
  • Most cancer treatments, including chemotherapy and radiation, function by inducing apoptosis in cancer cells.

Purpose of the Study:

  • To elucidate the molecular mechanisms governing apoptosis.
  • To understand how tumor cells evade apoptotic deletion.
  • To identify novel therapeutic targets for cancer treatment by understanding drug-induced apoptosis.

Main Methods:

  • Literature review of molecular events regulating apoptosis.
  • Analysis of cancer genetics and response to therapy.
  • Investigation of mechanisms underlying drug-induced apoptosis.

Main Results:

  • Apoptosis is a fundamental process in tissue regulation.
  • Cancer cells' evasion of apoptosis is a key factor in treatment resistance.
  • Understanding apoptosis regulation provides a link between cancer genetics and therapeutic outcomes.

Conclusions:

  • Targeting the molecular mechanisms of drug-induced apoptosis can lead to novel cancer therapies.
  • Further research into apoptosis evasion strategies in tumors is warranted.
  • Insights into apoptosis are critical for advancing cancer treatment strategies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...